Nyxoah (NYXH) has released an update.
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Nyxoah has launched its Genio system in England, marking a significant milestone in providing innovative treatment for Obstructive Sleep Apnea (OSA). The first successful implants were conducted at University College London Hospitals, underlining the system’s potential to address unmet needs in OSA therapy. With NHS coverage, Nyxoah aims to expand its collaboration with leading hospitals and enhance access to this groundbreaking therapy.
For further insights into NYXH stock, check out TipRanks’ Stock Analysis page.